LABORATORY NEWS
-
Roche Receives FDA Approval For Companion Diagnostic Tests To Identify Patients With HER2-Positive Metastatic Gastroesophageal Adenocarcinoma Eligible For ZIIHERA
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA approval for expanded use of its PATHWAY® HER2 (4B5) and VENTANA® HER2 Dual ISH DNA Probe Cocktail tests.
- Ataraxis AI's Laboratory Receives CAP Accreditation And California Clinical Laboratory License
- Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers For Isotope Ratio Analysis, Enabling More Labs To Decode The Story Behind A Sample
- Labcorp To Offer First FDA-Cleared Blood Test To Detect Alzheimer's Disease Pathology In Both Primary And Specialty Care Settings
- Quest Diagnostics To Offer FDA-Cleared Roche pTau217 Blood Test To Assess Alzheimer's Disease Pathology
ARCHIVED NEWSLETTER
- 08.25.26 -- GHK-Cu Peptide Launched By Kylo Peptides For Laboratory Research Applications
- 07.21.26 -- Reassessing Nanoparticle Immunotoxicity: From Well-Established To Novel Approaches
- 07.07.26 -- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis
- 05.26.26 -- Engineering Repeat-Dose RNA: Engineering Around Immune Recognition In Repeat-Dose RNA Therapeutics
- 04.21.26 -- Proteomics Tools: A Resurrection